BACKGROUND: Disease modifying treatments (DMTs) currently under development for Alzheimer's disease, have the potential to prevent or postpone institutionalization and more expensive care and might delay institutionalization of persons with dementia.OBJECTIVE: The current study estimates costs of living in a nursing home for persons with dementia in the Netherlands to help inform economic evaluations of future DMTs.METHODS: Data were collected during semi-structured interviews with healthcare professionals and from the financial administration of a healthcare organization with several nursing homes. Personnel costs were calculated using a bottom-up approach by valuing the time estimates. Non-personnel costs were calculated using information...
<div><p>Background</p><p>Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neu...
Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neuropsychiatric symptoms in...
Objectives: To examine the costs of caring for community-dwelling patients with Alzheimer’s disease ...
BACKGROUND: Disease modifying treatments (DMTs) currently under development for Alzheimer's disease,...
BACKGROUND: Disease modifying treatments (DMTs) currently under development for Alzheimer's disease,...
Dementia is the most common cause of functional decline among elderly people and is associated with ...
Dementia is the most common cause of functional decline among elderly people and is associated with ...
Dementia is the most common cause of functional decline among elderly people and is associated with ...
Dementia is the most common cause of functional decline among elderly people and is associated with ...
Dementia is the most common cause of functional decline among elderly people and is associated with ...
Contains fulltext : 136996.pdf (publisher's version ) (Open Access)BACKGROUND: Dem...
© 2014, Springer-Verlag Berlin Heidelberg. Background: Dementia is the most common cause of function...
BACKGROUND: Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neuropsychiatric...
OBJECTIVE: Rising life expectancy is associated with higher prevalence rates of dementia disorders. ...
Background: Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neuropsychiatric...
<div><p>Background</p><p>Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neu...
Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neuropsychiatric symptoms in...
Objectives: To examine the costs of caring for community-dwelling patients with Alzheimer’s disease ...
BACKGROUND: Disease modifying treatments (DMTs) currently under development for Alzheimer's disease,...
BACKGROUND: Disease modifying treatments (DMTs) currently under development for Alzheimer's disease,...
Dementia is the most common cause of functional decline among elderly people and is associated with ...
Dementia is the most common cause of functional decline among elderly people and is associated with ...
Dementia is the most common cause of functional decline among elderly people and is associated with ...
Dementia is the most common cause of functional decline among elderly people and is associated with ...
Dementia is the most common cause of functional decline among elderly people and is associated with ...
Contains fulltext : 136996.pdf (publisher's version ) (Open Access)BACKGROUND: Dem...
© 2014, Springer-Verlag Berlin Heidelberg. Background: Dementia is the most common cause of function...
BACKGROUND: Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neuropsychiatric...
OBJECTIVE: Rising life expectancy is associated with higher prevalence rates of dementia disorders. ...
Background: Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neuropsychiatric...
<div><p>Background</p><p>Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neu...
Dementia-care mapping (DCM) is a cyclic intervention aiming at reducing neuropsychiatric symptoms in...
Objectives: To examine the costs of caring for community-dwelling patients with Alzheimer’s disease ...